Mimedx (MDXG) Leases (2017 - 2025)
Mimedx recorded quarterly Leases of $4.3 million in Q4 2025, down 6.94% quarter-over-quarter from $4.7 million in Q3 2025, and down 22.51% year-over-year from $5.6 million in Q4 2024.
Mimedx's Leases history runs 8 years deep, the most recent figure standing at $4.3 million for Q4 2025.
- In Q4 2025, Leases fell 22.51% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (down 22.51% YoY), while the FY2025 annual figure was $4.3 million, down 22.51% from the prior year.
- Leases came in at $4.3 million for Q4 2025 at Mimedx, down from $4.7 million in the prior quarter.
- In the past five years, Leases ranged from a high of $5.6 million in Q4 2024 to a low of $189000.0 in Q2 2021.
- A 5-year average of $3.4 million and a median of $3.4 million in 2022 frame the typical range for Leases.
- Across the five-year window, Leases tumbled 95.31% in 2021 and jumped 2042.33% in 2022, its largest moves.
- Mimedx's Leases stood at $4.7 million in 2021, then declined by 27.6% to $3.4 million in 2022, then plunged by 37.29% to $2.1 million in 2023, then jumped by 162.95% to $5.6 million in 2024, then dropped by 22.51% to $4.3 million in 2025.
- According to Business Quant data, Leases over the past three periods registered $4.3 million, $4.7 million, and $5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 4.67 Mn |
| Jun 30, 2025 | 4.99 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 3.18 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | 3.07 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 4.36 Mn |
| Dec 31, 2021 | 4.70 Mn |
| Sep 30, 2021 | 189,000.00 |
| Jun 30, 2021 | 189,000.00 |
| Mar 31, 2021 | 3.39 Mn |
| Sep 30, 2020 | 4.03 Mn |
| Jun 30, 2020 | 2.91 Mn |
| Mar 31, 2020 | 3.16 Mn |
| Dec 31, 2019 | 3.40 Mn |
| Sep 30, 2019 | 3.63 Mn |
| Jun 30, 2019 | 3.85 Mn |
| Mar 31, 2019 | 4.08 Mn |
| Dec 31, 2017 | 997,000.00 |